Tocqueville Asset Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-15,250
Closed -$1.62M 1548
2014
Q2
$1.62M Sell
15,250
-18,350
-55% -$1.8M 0.02% 501
2014
Q1
$2.92M Buy
33,600
+4,600
+16% +$355K 0.04% 328
2013
Q4
$1.22M Buy
29,000
+4,500
+18% +$185K 0.02% 428
2013
Q3
$1.08M Sell
24,500
-1,000
-4% -$41.4K 0.01% 501
2013
Q2
$869K Buy
+25,500
New +$895K 0.01% 530

Tocqueville Asset Management's FURX Position: Q3 2014 in Review

Tocqueville Asset Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 15,250 shares — an estimated $1.62M sold.

Tocqueville Asset Management first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $2.92M in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Tocqueville Asset Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Tocqueville Asset Management sold 15,250 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $1.62M.
  • Tocqueville Asset Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Tocqueville Asset Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.92M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Tocqueville Asset Management's 13F filing for Q3 2014, filed 30 Oct 2014.